Form 4: J&J CEO Duato Reports 73,054 PSU Vesting

Johnson & Johnson CEO Joaquin Duato reported the vesting of 73,054 Performance Share Units, reflecting the achievement of performance conditions.

Summary

• Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson (JNJ), reported a change in beneficial ownership.
• The transaction involved the acquisition of 73,054 Performance Share Units (PSUs) on February 9, 2026.
• These PSUs were originally granted on February 13, 2023, under the Issuer's Long-Term Incentive Plan.
• The reported number of PSUs reflects the target amount, adjusted based on the achievement of performance conditions, which were certified on February 9, 2026.
• The PSUs convert into shares of Common Stock upon vesting, with a deemed execution date and exercisable date of February 13, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine disclosure of executive compensation, with a slightly positive undertone as it confirms the achievement of performance targets for the CEO's PSUs.

Positives

• The vesting of 73,054 Performance Share Units indicates that the performance conditions set forth in the award agreement were successfully met.
• This aligns the CEO's incentives with the company's long-term performance and shareholder value creation.

Future Outlook

The filing indicates the successful achievement of past performance conditions tied to executive compensation, which could imply positive operational performance during the relevant period. However, it does not provide explicit forward-looking statements or guidance on future company performance.

Management Comments

• The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance share units is a common practice in the pharmaceutical and consumer health industry. This structure aims to align executive incentives with long-term shareholder value creation and operational excellence, a standard across large-cap companies like Johnson & Johnson.

Comparison to Industry Standards

• The use of Performance Share Units (PSUs) as a component of executive compensation is a widely adopted practice among global pharmaceutical and healthcare giants, including Pfizer, Merck, and Novartis, to incentivize long-term performance.
• The vesting of PSUs based on certified performance conditions is consistent with best practices in corporate governance, ensuring that executive rewards are directly linked to the achievement of pre-defined strategic and financial targets, similar to programs at companies like Abbott Laboratories and Medtronic.

Stakeholder Impact

• Shareholders: The vesting of PSUs for the CEO indicates that performance targets were met, which is generally positive for shareholder value.
• Employees: May signal a positive internal environment if executive performance targets are being met.

Next Steps

• The Performance Share Units (PSUs) will convert into shares of Common Stock upon vesting.

Key Dates

Recommendation

This Form 4 filing is a routine disclosure of executive compensation related to the vesting of Performance Share Units. It indicates that performance conditions were met, which is a positive sign regarding past operational execution. However, it does not provide new material information about the company's future prospects, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific filing.

Keywords

Johnson & Johnson, JNJ, Joaquin Duato, Performance Share Units, PSUs, Insider Transaction, SEC Form 4, Executive Compensation, Long-Term Incentive Plan, Stock Award